Jove
Visualize
Contact Us

Related Experiment Videos

Harmine action in rats with lymphostatic encephalopathy

G Back, G Seidel

    Pharmacology
    |January 1, 1977
    PubMed
    Summary

    Lymphostatic encephalopathy impairs lymphatic drug elimination from the brain in rats, slowing harmine clearance. However, the blood-brain barrier remains functional for harmine distribution.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Panuveitis under dabrafenib/trametinib treatment for malignant cutaneous melanoma persisting after completion of treatment].

    Die Ophthalmologie·2024
    Same author

    [Central retinal vein thrombosis in a 21-year-old man-What is the cause?]

    Die Ophthalmologie·2022
    Same author

    Into the Blue: First in Man Data on Diving Physiology in Fontan Patients.

    Pediatric cardiology·2022
    Same author

    [Rapidly progressive neuropathy, diffuse pain and pseudohallucinations in a young female patient].

    Der Nervenarzt·2022
    Same author

    [Overlap syndrome between primary T cell-mediated vasculitis of the brainstem and chronic lymphocytic inflammation with pontocerebellar perivascular enhancement responsive to steroids (CLIPPERS)].

    Der Nervenarzt·2020
    Same author

    [Isolated metamorphopsia and visual pseudohallucinations in a patient with anti-NMDA receptor encephalitis].

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2020
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Toxicology

    Background:

    • Lymphostatic encephalopathy is a condition affecting brain lymphatic drainage.
    • Understanding drug disposition in the brain is crucial for effective therapeutic strategies.
    • Harmine is a psychoactive alkaloid used to study drug effects on the central nervous system.

    Purpose of the Study:

    • To investigate the impact of lymphostatic encephalopathy on harmine pharmacokinetics in the brain.
    • To assess the integrity of the blood-brain barrier in the presence of lymphostatic encephalopathy.
    • To determine if lymphatic drug elimination from the brain is altered in this condition.

    Main Methods:

    • Rats were induced with lymphostatic encephalopathy or underwent sham surgery.
    • Harmine was administered, and tremor duration was recorded.
    • Harmine concentrations in brain and plasma were measured over time.

    Main Results:

    • The duration of harmine-induced tremor was significantly longer in rats with lymphostatic encephalopathy.
    • Brain harmine concentrations decreased more slowly in lymphostatic encephalopathy rats compared to controls.
    • Plasma harmine concentrations were unaffected by lymphostatic encephalopathy, and tremor onset/cessation occurred at similar brain harmine levels in both groups.

    Conclusions:

    • Lymphatic drug elimination from the brain is impaired during lymphostatic encephalopathy.
    • The blood-brain barrier's function remains normal for harmine in this condition.
    • These findings highlight altered drug clearance mechanisms in the brain due to lymphatic dysfunction.

    Related Experiment Videos